Yes - they are a very competitive research hospital - and that's an understatement! We'll all look forward to more details. A dual action drug was my last nights imagining...Kevetrin for leukemia and blood cancers, the erythropoietin agent in combo for the anemias related to those cancers. Of course - we don't know what molecule ctix is interested in. The eryth one is a guess and given the hundreds of compounds this facility has under study every year - it is more likely to be an incorrect guess than a correct one! Thank for that link!